Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

Areas of Research Being Advanced by FARA Grants


We believe that investing in FA research will lead to the discovery and advancement of meaningful treatments and a cure for FA. In the past 5 years the FARA research grant program provided close to 30 million dollars to advance FA research.

The ultimate goal of the FARA grant program is to further therapeutic discovery and development by funding projects related to basic, translational and clinical research. The program is designed to fundestablished and new investigators in the FA field, both in academic and industry settings and promotecollaborations among scientists. In 2020, 16 new grants were funded, spanning nearly all areas of research, and 21 grants approved in previous years received continued funding. 13 of the new grants were awarded to investigators who had not previously received FARA funding, including 3 junior investigators. Currently, researchers in 8 countries are receiving funding from the FARA research grant program.

As of March 1st, 2021 FARA has already committed almost 6 million dollars to funding research for the current year, as we initiate and continue programs that will fill gaps in our understanding of FA, promote drug discovery, bring new research resources to the community, grow our Collaborative Clinical Research Network in FA (CCRN), fund new biomarker consortia and clinical research infrastructure to facilitate clinical trials.



+  Drug Discovery 

+  Gene & Stem Cell Therapy 

+  Lead Candidates 

+  Mechanism or Pathway of Disease 

+  Cell & Animal Models 

+  Natural Hx & Biorepository 

+  Outcome Measures & Biomarkers 

+  Cardiac Research 

+  Improving Clinical Outcomes 

 
 
   2020 Awards    2019 Awards
   2018 Awards    2017 Awards
   2016 Awards    2015 Awards
   2014 Awards    2013 Awards
   2012 Awards    2011 Awards
   2010 Awards    2009 Awards
   2008 Awards    2007 Awards
   2006 Awards    2005 Awards
 
 
 

Grant program updates and announcements

View special interest RFPs and other grant program updates and announcements here.

Newly awarded grants

Cell & Animal Models

Paola Costantini, PhD - University of Padova, Italy​ Three-dimensional mature cardiac microtissues from human induced pluripotent stem cells to explore mitochondrial dynamics, cardiac function and therapeutic options in Friedreich Ataxia

Gene & Stem Cell Therapy​

Jill Napierala, PhD - University of Alabama at Birmingham​ Regulation of frataxin expression - implications for Friedreich's ataxia therapy​
Helene Puccio, PhD - Institute NeuroMyoGène, Lyon, France​ Defining the therapeutic window and threshold for neuronal gene therapy in Friedreich Ataxia​

Mechanism or Pathway of Disease​

Arnulf Koeppen, MD - VA Medical Center, Albany​ The pathogenesis of the major neural lesions in Friedreich ataxia: dorsal root ganglion and dentate nucleus​


Are you subscribed to our science newsletter, Friedreich's ataxia Community Research News?
If you are not a subscriber, please click here to sign-up!

SHARE

FacebookTwitterLinkedInYoutube
Family D.jpg
Site Map     Privacy Policy     Service Terms     Log-in     Contact     Charity Navigator